AbbVie will test lutikizumab together with ABBV-295, the amylin-based obesity drug it licensed from Danish biotech Gubra, ...

China has more house dust mite allergy sufferers than any other country, but fewer than 1 million of an estimated 100 million ...

All major hearing aid makers are launching new premium devices at the same time, but Søren Nielsen expects audiologists to ...

On Thursday evening, Bioporto was able to delight investors with a US marketing approval for the kidney test NGAL for patients between the ages of three months and 21 years. The US Food and Drug ...

EU panel backs Eli Lilly’s Foundayo obesity pill Eli Lilly is still awaiting final approval from the European Commission.

In May, Demant achieved its highest ever market share in the Veterans Affairs (VA) sales channel. This follows the launch of the top product Oticon Intent, which was made available on May 1. And it ...

Novo regains GLP-1 market share in Europe and Canada, executive says The gains partly offset a decline in China, Asia-Pacific and emerging markets, where the company’s market share is shrinking.

Novo signs deal worth up to EUR 1.165bn with Sweden's Nanexa The Danish drugmaker gains access to Nanexa’s drug delivery technology, which could allow monthly or quarterly dosing of weight-loss and ...

US pharma lobby group names new chief executive Former Republican Majority Leader Eric Cantor is set to take the helm at PhRMA following Steve Ubl’s who har served more than ten years in the position.